Patent ID: 11873304
Assignee: INCYTE CORPORATION
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 31:
32. The method of claim 2, wherein each R8B is independently selected from halo, C1-6 alkyl, C1-6 haloalkyl, C2-6 alkenyl, C2-6 alkynyl, CN, ORa82, SRa82, C(O)Rb82, C(O)NRc82Rd82, C(O)ORa82, OC(O)Rb82, OC(O)NRc82Rd82, NRc82Rd82, NRc82NRc82Rd82, NRc82C(O)Rb82, NRc82C(O)ORa82, NRc82C(O)NRcs82Rd82, NRc82S(O)2Rb82, NRc82S(O)2NRc82Rd82, S(O)2Rb82, and S(O)2NRc82Rd82, wherein the C1-6 alkyl, C2-6 alkenyl, and C2-6 alkynyl of R8B are each optionally substituted with 1, 2, 3, or 4 independently selected R8C substituents; and
wherein each Ra82, Rb82, Rc82, and Rd82 is independently selected from H, C1-6 alkyl, C1-6 haloalkyl, C2-6 alkenyl, and C2-6 alkynyl, wherein the C1-6 alkyl, C2-6 alkenyl, and C2-6 alkynyl of Ra82, Rb82, Rc82 and Rd82 are each optionally substituted with 1, 2, 3, or 4 independently selected R8C substituents.